CHU Nimes
Nîmes, Gard, 30000, France
NCT Number: NCT02809742
Enhanced patient safety and satisfaction have contributed to growing use of epidural labor analgesia. Epidural analgesia appears to be currently the most effective technique in reducing pain during labor. However, reduction in total dose of local anesthetic and thus motor blockade is crucial to improve the obstetric outcome. This technique has evolved from intermittent boluses by anesthesiologists to the current standard labor epidural analgesic regimens in many institutions in North America and Europe that consist of a local anesthetic in combination with an opioid delivered via continuous epidural infusion (CEI) with or without patient-controlled epidural analgesia (PCEA) boluses. Recently,a new mode of administration has been used: regular bolus of low concentration local anesthetic + intermittent bolus (PIEB). This technique would offer safe and superior quality labor analgesia and greater maternal satisfaction by reducing total amount of the drug combination.
The primary outcome was to evaluate the analgesic efficacy of PIEB epidural drug delivery in terms of visual analogue scale satisfaction (VAS) score in a large cohort of patients. The secondary outcomes were to measure the degree of motor blockade, neonatal and obstetric outcomes, total drug dose and incidence of pain that required top-up administration (breakthrough pain)
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Nîmes, Gard, 30000, France
Patients were explained about the procedure and written informed consent was obtained. Healthy term primi or second gravid parturients (aged >18 years) with a singleton, live fetus in vertex presentation when in active stage of labor with cervical dilation of 3-5 cm were recruited in the study after they requested epidural for pain relief. PIEB epidural analgesia was used.
Primary outcome was maternal satisfaction during labor and delivery. Our hypothesis was that patients would have a greater level of satisfaction when using PIEB technique. The secondary outcomes were to measure the degree of motor blockade, neonatal and obstetric outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Epidural : automatic intermittent boluses associated with patient controlled bolus using ropivacaine
Other names: ropivacaine 2 mg/ml
Time frame: 1 day
VASS: 0-10: 0 = no satisfaction to 10 (total satisfaction)
Time frame: 1 day
Evaluation of adverse events over epidural infusion (mean arterial pressure< 65 mmHg)
Time frame: 1 day
The Apgar test is done by a doctor, midwife, or nurse. The health care provider examines the baby's:
Each category is scored with 0, 1, or 2, depending on the observed condition.
Time frame: 1 day
Evaluation of the rescue performed by anesthesist over infusion
Time frame: 1 day
Number of maternal nausea event
Time frame: 1 day
Fetal heart sounds were monitored with a continuous Doppler machine
Time frame: 1 day
Bromage score for maternal motor block
Pierre and Marie Curie University
Other
Intermittent Bolus Administration of Ropivacaine for Epidural Labor Analgesia : an Observational Study
Acronym: OptimEpi
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07278895
Agnosia, Analgesia, Epidural
Diyarbakır, Outside of the US, Turkey (Türkiye)
View Trial DetailsNCT07451834
Agnosia, Labor Pain
Karatay, Konya, Turkey (Türkiye)
View Trial DetailsNCT03975660
Agnosia, Analgesia
Stanford, California, United States
View Trial DetailsNCT06266767
Agnosia, Analgesia
Doha, Baladiyat ad Dawhah, Qatar
View Trial Details